Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Tihana Kurtović"'
Autor:
Dubravko Forčić, Karmen Mršić, Melita Perić-Balja, Tihana Kurtović, Snježana Ramić, Tajana Silovski, Ivo Pedišić, Ivan Milas, Beata Halassy
Publikováno v:
Vaccines, Vol 12, Iss 9, p 958 (2024)
Intratumoural oncolytic virotherapy may have promise as a means to debulk and downstage inoperable tumours in preparation for successful surgery. Here, we describe the unique case of a 50-year-old self-experimenting female virologist with locally rec
Externí odkaz:
https://doaj.org/article/fffd39ceb5014a74baa397874826022b
Autor:
Sanda Ravlić, Tihana Kurtović, Lidija Cvetko Krajinović, Ana Hećimović, Marija Miloš, Sanja Mateljak Lukačević, Alemka Markotić, Beata Halassy
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 3 (2023)
ABSTRACTDuring the SARS-CoV-2 pandemic, the lack of standardized measurements of the immune response after vaccination or recovery from COVID-19 resulted in incomparable results and hindered correlation establishment. Prioritizing reliable and standa
Externí odkaz:
https://doaj.org/article/1fa9504d47a54ba9860358532c9e9406
Publikováno v:
Toxins, Vol 15, Iss 6, p 398 (2023)
Envenomations induced by animal bites and stings constitute a significant public health burden. Even though a standardized protocol does not exist, parenterally administered polyclonal antivenoms remain the mainstay in snakebite therapy. There is a p
Externí odkaz:
https://doaj.org/article/034c0960bf5e417991209c5defb79815
Publikováno v:
Molecules, Vol 28, Iss 11, p 4567 (2023)
The multi-detection size exclusion chromatography (SEC) has been recognized as an advanced analytical technique for the characterization of macromolecules and process control, as well as the manufacturing and formulation of biotechnology products. It
Externí odkaz:
https://doaj.org/article/0b7a38754f08411ab08d7acbd585e7e2
Autor:
Tihana Kurtović, Sanda Ravlić, Adela Štimac, Sanja Mateljak Lukačević, Ana Hećimović, Saša Kazazić, Beata Halassy
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
During the pre-vaccine era of the COVID-19 pandemic convalescent plasma has once again emerged as a major potential therapeutic form of passive immunization that in specific cases still represents irreplaceable treatment option. There is a growing co
Externí odkaz:
https://doaj.org/article/587d107a1ed64c3ab4879acaf7641de1
Autor:
Sanda Ravlić, Ana Hećimović, Tihana Kurtović, Jelena Ivančić Jelečki, Dubravko Forčić, Anamarija Slović, Ivan Christian Kurolt, Željka Mačak Šafranko, Tatjana Mušlin, Dina Rnjak, Ozren Jakšić, Ena Sorić, Gorana Džepina, Oktavija Đaković Rode, Kristina Kujavec Šljivac, Tomislav Vuk, Irena Jukić, Alemka Markotić, Beata Halassy
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
During the ongoing COVID-19 epidemic many efforts have gone into the investigation of the SARS-CoV-2–specific antibodies as possible therapeutics. Currently, conclusions cannot be drawn due to the lack of standardization in antibody assessments. He
Externí odkaz:
https://doaj.org/article/dad249e3f4cf4878bf54efa90cc2ac10
Publikováno v:
Toxins, Vol 14, Iss 7, p 483 (2022)
Antivenoms contain either pure animal IgGs or their fragments as an active substance, and are the only specific therapeutics against envenomation arising from snakebites. Although they are highly needed, the low sustainability of such preparations’
Externí odkaz:
https://doaj.org/article/b22c929a49854bfaa6d2e74c789e8a3c
Publikováno v:
Molecules, Vol 27, Iss 5, p 1665 (2022)
Quality control of human immunoglobulin formulations produced by caprylic acid precipitation necessitates a simple, rapid, and accurate method for determination of residual caprylic acid. A high-performance liquid chromatography method for that purpo
Externí odkaz:
https://doaj.org/article/964933dd3c904c12b4339b7ac6445a84
Autor:
Tihana Kurtović, Marija Brgles, Maja Lang Balija, Stephanie Steinberger, Dora Sviben, Martina Marchetti-Deschmann, Beata Halassy
Publikováno v:
Journal of Venomous Animals and Toxins including Tropical Diseases, Vol 26 (2020)
Abstract Background: Antivenoms are the only validated treatment against snakebite envenoming. Numerous drawbacks pertaining to their availability, safety and efficacy are becoming increasingly evident due to low sustainability of current productions
Externí odkaz:
https://doaj.org/article/99c1ce2a234c4c67ae62bada9f56bf83
Autor:
Tihana Kurtović, Maja Lang Balija, Marija Brgles, Dora Sviben, Monika Tunjić, Hrvoje Cajner, Martina Marchetti-Deschmann, Günter Allmaier, Beata Halassy
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 6, p e0007431 (2019)
Antivenoms from hyperimmune animal plasma are the only specific pharmaceuticals against snakebites. The improvement of downstream processing strategies is of great interest, not only in terms of purity profile, but also from yield-to-cost perspective
Externí odkaz:
https://doaj.org/article/fcd1cf5a11c74ee19683bc7ecb217d3d